Quantitative analysis of O⁶-methylguanine DNA methyltransferase (MGMT) promoter methylation in patients with low-grade gliomas

By Ochsenbein Adrian   Schubert Adrian   Vassella Erik   Mariani Luigi  

Journal of Neuro-Oncology, Vol. 103, Iss. 2, 2011-06 ,pp. : 343-351

Springer Publishing Company

Access to resources Recommend Favorite

MGMT promoter methylation status in anaplastic meningiomas

By Brokinkel Benjamin   Fischer Bernhard   Peetz-Dienhart Susanne   Ebel Heinrich   Sepehrnia Abolghassem   Rama Burckhard   Albert Friedrich   Stummer Walter   Paulus Werner   Hasselblatt Martin  

Journal of Neuro-Oncology, Vol. 100, Iss. 3, 2010-12 ,pp. : 489-490

Springer Publishing Company

Access to resources Recommend Favorite

Correlation of Clinical Features and Methylation Status of MGMT Gene Promoter in Glioblastomas

By Blanc J.L.   Wager M.   Guilhot J.   Kusy S.   Bataille B.   Chantereau T.   Lapierre F.   Larsen C.J.   Karayan-Tapon L.  

Journal of Neuro-Oncology, Vol. 68, Iss. 3, 2004-07 ,pp. : 275-283

Springer Publishing Company

Access to resources Recommend Favorite

MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas

By Salehi Fateme  

Journal of Neuro-Oncology, Vol. 104, Iss. 3, 2011-09 ,pp. : 647-657

Springer Publishing Company

Access to resources Recommend Favorite

MGMT promoter methylation and temozolomide response in choroid plexus carcinoma

By Misaki Kouichi  

Brain Tumor Pathology, Vol. 28, Iss. 3, 2011-07 ,pp. : 259-263

Springer Publishing Company

Access to resources Recommend Favorite